Literature DB >> 30648461

Cellular Senescence: Aging, Cancer, and Injury.

Arianna Calcinotto1, Jaskaren Kohli1, Elena Zagato1, Laura Pellegrini1, Marco Demaria1, Andrea Alimonti1.   

Abstract

Cellular senescence is a permanent state of cell cycle arrest that occurs in proliferating cells subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that prevents the cells to acquire an unnecessary damage. The senescent state is accompanied by a failure to re-enter the cell cycle in response to mitogenic stimuli, an enhanced secretory phenotype and resistance to cell death. Senescence takes place in several tissues during different physiological and pathological processes such as tissue remodeling, injury, cancer, and aging. Although senescence is one of the causative processes of aging and it is responsible of aging-related disorders, senescent cells can also play a positive role. In embryogenesis and tissue remodeling, senescent cells are required for the proper development of the embryo and tissue repair. In cancer, senescence works as a potent barrier to prevent tumorigenesis. Therefore, the identification and characterization of key features of senescence, the induction of senescence in cancer cells, or the elimination of senescent cells by pharmacological interventions in aging tissues is gaining consideration in several fields of research. Here, we describe the known key features of senescence, the cell-autonomous, and noncell-autonomous regulators of senescence, and we attempt to discuss the functional role of this fundamental process in different contexts in light of the development of novel therapeutic targets.

Entities:  

Mesh:

Year:  2019        PMID: 30648461     DOI: 10.1152/physrev.00020.2018

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  184 in total

Review 1.  Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities.

Authors:  Zhijie Xu; Jinzhou Huang; Ming Gao; Guijie Guo; Shuangshuang Zeng; Xi Chen; Xiang Wang; Zhicheng Gong; Yuanliang Yan
Journal:  Geroscience       Date:  2020-06-11       Impact factor: 7.713

2.  Current perspectives on the cellular and molecular features of epigenetic ageing.

Authors:  Kenneth Raj; Steve Horvath
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-10

3.  COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence.

Authors:  Chen-Yu Zhang; Jia-Xi Duan; Hui-Hui Yang; Chen-Chen Sun; Wen-Jing Zhong; Jia-Hao Tao; Xin-Xin Guan; Hui-Ling Jiang; Bruce D Hammock; Sung Hee Hwang; Yong Zhou; Cha-Xiang Guan
Journal:  FEBS J       Date:  2019-11-08       Impact factor: 5.542

4.  Retinoic acid inducible gene-I slows down cellular senescence through negatively regulating the integrin β3/p38 MAPK pathway.

Authors:  Junmei Zhao; Xinyi Jiang; Li Yan; Jian Lin; Hezhou Guo; Shanhe Yu; Baixin Ye; Jiang Zhu; Wu Zhang
Journal:  Cell Cycle       Date:  2019-10-09       Impact factor: 4.534

Review 5.  Cellular and molecular mechanisms of xenobiotics-induced premature senescence.

Authors:  Yuehui Liang; Ningjuan Liang; Lirong Yin; Fang Xiao
Journal:  Toxicol Res (Camb)       Date:  2020-10-01       Impact factor: 3.524

Review 6.  How the ageing microenvironment influences tumour progression.

Authors:  Mitchell Fane; Ashani T Weeraratna
Journal:  Nat Rev Cancer       Date:  2019-12-13       Impact factor: 60.716

Review 7.  Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.

Authors:  Sugandha Saxena; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

8.  Algorithmic assessment of cellular senescence in experimental and clinical specimens.

Authors:  J Kohli; B Wang; S M Brandenburg; N Basisty; K Evangelou; M Varela-Eirin; J Campisi; B Schilling; V Gorgoulis; M Demaria
Journal:  Nat Protoc       Date:  2021-04-28       Impact factor: 13.491

Review 9.  Small-molecule drug repurposing to target DNA damage repair and response pathways.

Authors:  Jacqueline A Brinkman; Yue Liu; Stephen J Kron
Journal:  Semin Cancer Biol       Date:  2020-02-27       Impact factor: 15.707

Review 10.  Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.

Authors:  Xia Liu; Daniel F Hoft; Guangyong Peng
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.